相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mycophenolate mofetil treatment in patients with autoimmune hepatitis failing standard therapy with prednisolone and azathioprine
Georgios Giannakopoulos et al.
DIGESTIVE AND LIVER DISEASE (2019)
Systematic review with meta-analysis: mycophenolate mofetil as a second-line therapy for autoimmune hepatitis
Priscila Santiago et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
Efficacy and Safety of Mycophenolate Mofetil in Patients With Autoimmune Hepatitis and Suboptimal Outcomes After Standard Therapy
Stuart K. Roberts et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)
Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients With Autoimmune Hepatitis
Cumali Efe et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2017)
Immunosuppressive drugs affect interferon (IFN)- and programmed cell death 1 (PD-1) kinetics in patients with newly diagnosed autoimmune hepatitis
C. R. Grant et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2017)
A real-world study focused on the long-term efficacy of mycophenolate mofetil as first-line treatment of autoimmune hepatitis
K. Zachou et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
EASL Clinical Practice Guidelines: Autoimmune hepatitis
JOURNAL OF HEPATOLOGY (2015)
Autoimmune hepatitis: A comprehensive review
Rodrigo Liberal et al.
JOURNAL OF AUTOIMMUNITY (2013)
Liver Transplantation and Autoimmune Liver Diseases
Rodrigo Liberal et al.
LIVER TRANSPLANTATION (2013)
Clinical significance of azathioprine metabolites for the maintenance of remission in autoimmune hepatitis
Harpreet K. Dhaliwal et al.
HEPATOLOGY (2012)
The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes
A. M. C. Baven-Pronk et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Overlap syndromes: The International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue
Kirsten Muri Boberg et al.
JOURNAL OF HEPATOLOGY (2011)
Mycophenolate Mofetil Monotherapy in Liver Transplantation: 5-Year Follow-Up of a Prospective Randomized Trial
Maximilian Schmeding et al.
TRANSPLANTATION (2011)
Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory or intolerant to conventional therapy
Kaveh Sharzehi et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2010)
Diagnosis and Management of Autoimmune Hepatitis
Michael P. Manns et al.
HEPATOLOGY (2010)
Mycophenolate Mofetil for Autoimmune Hepatitis: A Single Practice Experience
David C. Wolf et al.
DIGESTIVE DISEASES AND SCIENCES (2009)
Mycophenolate Mofetil as Second Line Therapy in Autoimmune Hepatitis?
Elke M. Hennes et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
A single center review of the use of mycophenolate mofetil in the treatment of autoimmune hepatitis
Jonathan T. Hlivko et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Simplified criteria for the diagnosis of autoimmune hepatitis
Elke M. Hennes et al.
HEPATOLOGY (2008)
Mycophenolate mofetil in autoimmune hepatitis patients not responsive or intolerant to standard immunosuppressive therapy
Ira Inductivo-Yu et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Empiric therapy of autoimmune hepatitis with mycophenolate mofetil - Comparison with conventional treatment for refractory disease
AJ Czaja et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2005)
Indications of mycophenolate mofetil in liver transplantation
J Klupp et al.
TRANSPLANTATION (2005)
Transplant immunosuppressive agents in non-transplant chronic autoimmune hepatitis: the Canadian association for the study of liver (CASL) experience with mycophenolate mofetil and tacrolimus
N Chatur et al.
LIVER INTERNATIONAL (2005)
Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory to standard therapy
SM Devlin et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2004)
分享论文
